NorthStar Capital Advisors

The Principals of NorthStar Capital Advisors have served some of the most successful and innovative companies within the life science industry (in the United States, Europe and India) in sectors including pharmaceuticals, biotechnology, clinical and research diagnostics, medical equipment and devices, laboratory services, health care information technology, generic and specialty drugs

The Principals of NorthStar Capital Advisors have also originated, structured and completed licensing transactions, and industry sponsored research programs on behalf of universities, academic medical centers, research organizations.  These transaction have generated income and funding for research institutions while contributing to the R&D pipelines of Life Science companies.  Examples include:

  1. Washington State University, Pullman, WA - Research Collaboration for Cell Therapeutics, Inc
  2. University of Kentucky School of Medicine - Research Collaboration for Neurocrine Biosciences, Inc
  3. University of Iowa School of Pharmacy - Research and service collaboration - Neurocrine Biosciences, Inc
  4. Picower Institute, North Shore Hospital System, Long Island, NY - Licensed a number of technologies for Cytokine Networks, Inc
  5. University of Kentucky, School of Pharmacy, Research and Service collaboration for Cytokine Networks, Inc
  6. Oregon Health Science Center, Portland-License of technology for Novacea, Inc
  7. Arizona State University, Temple - License of technology for GPC Biotech, Inc
  8. Ohio State University, Columbus - Optioned a technology for Cascade Pharmaceuticals. Inc
  9. Southern Illinois University- Product license for Molecular Therapeutics, Inc
  10. University of Michigan, Ann Arbor, MI-Licensed various technologies for Molecular Therapeutics, Inc
  11. Sloan Kettering Cancer Center, New York - Licensed technology for Molecular Imaging Research, Inc
  12. California Pacific Medical Center, San Francisco - Product license for Innova Therapeutics, Inc
  13. Wayne State University, Detroit- Technology option for Nanoderma Therapeutics, Inc
  14. University of Michigan, Ann Arbor, MI-Optioned technology for Nanoderma Therapeutics, Inc
  15. University of Texas, Galveston - Optioned technology for Innova Therapeutics, Inc
  16. Stanford University, Stanford - Optioned technology for Nueroderma Therapeutics, Inc

In a challenging financial market environment, the Principals and Advisory Board of NorthStar Capital Advisors have succeeded in completing transactions in excess of $670 million (January, 2008 to December, 2009)